Gyroscope Therapeutics Holdings plc risk profile
68 Stretched several inputs deteriorating together
Measured 21 October 2026 from VISN's filed statements. Recomputed nightly.
68 (Stretched), driven by Market expectation at 76, over 4 weighted categories on the MANUFACTURER profile.
What is measured
| Mechanism | Reading | Band | Direction | Driver |
|---|---|---|---|---|
| Market expectation | 76 | Stretched | Volatile | One-year price volatility — 83.7% |
| Operating pressure | Reads cost_of_revenue, operating_expense, operating_income and revenue. No reading is stored for this company. | |||
| Cash conversion | 43 | Elevated | Worsening | Cash conversion — 0.14x |
| Leverage and coverage | 73 | Stretched | Easing | Net debt to EBITDA — 20.04x |
| Competitive position | 71 | Stretched | Stable | Revenue-growth gap against peers — -93.1 percentage points |
| Concentration | Reads identified supplier spend, customers above the 10% disclosure threshold and revenue by region. No reading is stored for this company. | |||
These are descriptive readings of disclosed mechanisms, not investment advice, and not a prediction. A band says where a measured input sits, never what to do about it or what happens next.
Technology companies with a risk reading
NVIDIA Corp 43Apple Inc 47Microsoft Corporation 33Taiwan Semiconductor Manufacturing 17Broadcom Inc 29Micron Technology Inc 42Advanced Micro Devices Inc 29ASML HOLDING 25ASML Holding NV 26Palantir Technologies Inc - Class A 17Intel Corp 54Cisco Systems Inc 57
Financials, valuation and price history for Gyroscope Therapeutics Holdings plc